Photocure ASA: Annual general meeting held
May 09, 2018 13:04 ET
|
Photocure ASA
Oslo, Norway, 9 May 2018: Photocure ASA (OSE: PHO), held its annual general meeting on 9 May 2018 at 17:00 hours (CET). All proposals were resolved as presented in the notice convening the annual...
Photocure ASA: Purchase own shares
May 08, 2018 11:14 ET
|
Photocure ASA
Reference is made to the stock exchange release on 7 May 2018 announcing a repurchase of 13,000 own shares. Photocure ASA purchased today, 8 May 2018, 13,000 own shares. The shares were purchased at...
Photocure ASA: Employee incentive program
May 07, 2018 16:07 ET
|
Photocure ASA
The board of directors of Photocure ASA resolved today a share capital increase as part of the employee long-term incentive program for restricted shares in the company. In addition, the board of...
Photocure ASA: Annual accounts 2017
April 16, 2018 09:50 ET
|
Photocure ASA
Oslo, 16 April 2018: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2017. The annual accounts and annual report for the financial year 2017 are...
Photocure ASA: Notice of the annual general meeting 9 May 2018
April 16, 2018 09:43 ET
|
Photocure ASA
Oslo, 16 April 2018: Photocure ASA (OSE: PHO), calls for the annual general meeting of PHO to be held at Hoffsveien 4, 1st floor, 0275 Oslo, Norway on 9 May 2018 at 17:00 hours (CET). The...
Photocure ASA: Results for the fourth quarter of 2017
February 27, 2018 01:15 ET
|
Photocure ASA
Oslo, Norway, 27 February 2018: Photocure ASA (OSE:PHO), today reported a revenue growth of 27% for the important U.S. market in the fourth quarter of 2017, contributing to Hexvix®/Cysview®...
Photocure ASA: Presentation of the fourth quarter and full year 2017 results
February 20, 2018 04:53 ET
|
Photocure ASA
Photocure will present its fourth quarter and full year 2017 report on Tuesday 27 February 2018 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives...
Photocure Announces U.S. FDA Approval of New Indications for Blue Light Cystoscopy with Cysview®
February 16, 2018 01:54 ET
|
Photocure ASA
Oslo, Norway, February 16, 2018 Photocure ASA (OSE: PHO), announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the...
Photocure ASA: Presentation at the DNB Nordic Healthcare Conference, Oslo
December 13, 2017 04:55 ET
|
Photocure ASA
Oslo, Norway, December 13, 2017 - Photocure ASA (OSE: PHO) announces today that the company will present at the DNB Nordic Healthcare Conference on 14th of December 2017 in Oslo, Norway. Presenter...
Photocure ASA: Landmark Blue Light Cystoscopy with Cysview® study is published in the Journal of Urology
December 08, 2017 02:19 ET
|
Photocure ASA
Oslo, Norway, December 8, 2017: Photocure ASA (Photocure, PHO: OSE), today announced that the official Journal of the American Urologic Association (AUA), the Journal of Urology, published the...